Patients with preserved residual kidney function experience a survival benefit.
Use of oral megestrol acetate (MA) is associate with significant adverse effects.
Dialysis providers and facilities should assess and improve infection control practices.
Factors include care practices of physicians, sources of momentum, patient-physician interactions.
In a phase 2 trial, etelcalcitide, a novel peptide agonist of the calcium-sensing receptor, significantly reduced parathyroid hormone levels.
Study shows benefit of initiating epoetin beta therapy at hemoglobin levels not less than 10 g/dL in non-dialysis CKD patients.
Serum total and free testosterone declined in men on hemodialysis who received a 6-month course of the drug for secondary hyperparathyroidism.
Lowest magnesium level was associated with a 74% increased risk of early death compared with mid-range levels.
Primary factor for nonadherence to renal dosing is characteristics of medical institution.
Six-months of supplementation has no impact on epoetin utilization in HD patients with low 25(OH)D.
Researchers observe significant improvements chronic and hemodialysis-induced vascular dysfunction.
Blacks undergoing PD or home HD and Hispanics undergoing PD are less likely than their white counterparts to receive a kidney transplant.
At the highest level, the ratings can be used to categorize facilities. They can also indicate which facilities may need more resources.
The estimated potential staff time savings totaled 23 hours for an average facility with 70 patients, researchers found.
Rates of death and important non-fatal outcomes between ferumoxytol and iron sucrose or sodium ferric gluconate do not differ significantly.
Prospective study shows no increase in all-cause mortality and cardiovascular events compared with non-use.
More adverse events seen when people undergoing interventional radiology have negative attitude.
Case report describes acyclovir-induced neurotoxicity in patient treated with recommended dose.
These factors include lower serum albumin levels and vascular access other than an arteriovenous fistula at dialysis initiation.
Dialysis, organ transplant may increase odds for certain types of cancer.
Having hemoglobin 9-11 g/dL prior to dialysis provided the best life expectancy.
It is unclear whether RDW is a risk factor for early death or a byproduct of biological and metabolic imbalances.
Veteran patients with levels below 100 mg/dL had a 26% higher risk of mortality compared with patients with triglyceride levels of 150-200 mg/dL.
Up to 100 mg per day raises plasma concentrations of ascorbic acid without increasing oxalate levels.
Patients prescribed the lipid-lowering agents were less likely to exhibit hyporesponsiveness to the medications.
Study finds no gender differences in parathyroid hormone, ferritin, Kt/V, or age.
In a study, the mean hemoglobin level increased significantly in hemodialysis patients with functional iron deficiency.
In an 8-week randomized trial, extended-release nalbuphine 120 mg BID significantly reduced itch severity compared with placebo.
In a 24-hour exploratory trial, all 7 patients who wore the device remained hemodynamically stable over the study period.
Phosphate and vitamin D deficiency were linked with RLS severity.
- Twice-Weekly Dialysis May Preserve Residual Kidney Function
- Robotic Nephrectomy of Kidney Tumors With Thrombi Feasible
- How to Prevent Sexual Transmission of Zika Virus
- Parathyroidectomy Cuts Mortality Risk in Patients With Severe SHPT
- Prostate Cancer Diagnosis Ups Risk of Non-Cancer Hospitalizations
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)